Dec 05, 2016 11:59 am UTC| Business
- Three Positive Phase 3 Epidiolex clinical trials reported in 2016 -- NDA submission and launch preparation on track -- Conference call today at 8:00 a.m. EST - LONDON, Dec. 05, 2016 -- GW Pharmaceuticals plc...
Tyson Foods Creates Venture Fund to Fuel the Future of Food
Dec 05, 2016 11:59 am UTC| Business
SPRINGDALE, Ark., Dec. 05, 2016 -- As part of its commitment to innovation and growth, Tyson Foods, Inc. (NYSE:TSN) has launched a venture capital fund focused on investing in companies developing breakthrough...
Comstock Mining Announces Favorable Supreme Court Rulings
Dec 05, 2016 11:45 am UTC| Business
VIRGINIA CITY, Nev., Dec. 05, 2016 -- Comstock Mining Inc. (the “Company”) (NYSE MKT:LODE) is pleased to announce that the Supreme Court of the State of Nevada affirmed the lower court’s decision relating to the Lyon...
Dec 05, 2016 11:30 am UTC| Business
- Company to pursue comparative bioavailability regulatory route instead of clinical efficacy development route -- NeuroDerm to add patients to its long-term safety trial -- Conference call and webcast today at 8:00 a.m....
WABCO Board of Directors Authorizes New Share Buyback Program Up To $600 Million
Dec 05, 2016 11:30 am UTC| Business
BRUSSELS, Belgium, Dec. 05, 2016 -- WABCO Holdings Inc. (NYSE:WBC) (www.wabco-auto.com), a leading global supplier of technologies and services that improve the safety, efficiency and connectivity of commercial...
Nokia showcases 5G innovations driving next era of communication
Dec 05, 2016 11:04 am UTC| Business
Demonstrations of latest 5G-related technologies at IEEE Globecom 2016 including dynamic spectrum and network automation to intelligently optimize capacityVisitors will be able to see spectrum access controller for Nokia...
Cesca Submits IDE Supplement for CLI Pivotal Trial
Dec 05, 2016 11:00 am UTC| Business
RANCHO CORDOVA, Calif., Dec. 05, 2016 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapeutics, today announced that on November 21,...